Chemoinformaics analysis of Malvidin-3-O-Alpha-L-Arabinoside
| Molecular Weight | 498.868 | nRot | 5 |
| Heavy Atom Molecular Weight | 475.684 | nRig | 23 |
| Exact Molecular Weight | 498.093 | nRing | 4 |
| Solubility: LogS | -3.397 | nHRing | 2 |
| Solubility: LogP | 1.168 | No. of Aliphatic Rings | 1 |
| Acid Count | 1 | No. of Aromatic Rings | 3 |
| Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 57 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 34 | No. of Aromatic Carbocycles | 2 |
| nHetero | 12 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 23 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 22 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 16 |
| No. of Oxygen atom | 11 | No. of Arom Bond | 17 |
| nHA | 10 | APOL | 63.0782 |
| nHD | 6 | BPOL | 31.7538 |
| QED | 0.302 |
| Synth | 4.162 |
| Natural Product Likeliness | 1.759 |
| NR-PPAR-gamma | 0.958 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.013 |
| Pgp-sub | 0.98 |
| HIA | 0.784 |
| CACO-2 | -6.289 |
| MDCK | 0.0000105 |
| BBB | 0.091 |
| PPB | 0.816233 |
| VDSS | 0.953 |
| FU | 0.250043 |
| CYP1A2-inh | 0.048 |
| CYP1A2-sub | 0.314 |
| CYP2c19-inh | 0.012 |
| CYP2c19-sub | 0.081 |
| CYP2c9-inh | 0.002 |
| CYP2c9-sub | 0.265 |
| CYP2d6-inh | 0.036 |
| CYP2d6-sub | 0.236 |
| CYP3a4-inh | 0.006 |
| CYP3a4-sub | 0.028 |
| CL | 10.17 |
| T12 | 0.859 |
| hERG | 0.036 |
| Ames | 0.685 |
| ROA | 0.037 |
| SkinSen | 0.125 |
| Carcinogencity | 0.053 |
| EI | 0.04 |
| Respiratory | 0.11 |
| NR-Aromatase | 0.897 |
| Antiviral | Yes |
| Prediction | 0.606366 |